These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26317998)

  • 1. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
    Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
    Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
    J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
    Qu H; Liu H; Jin Y; Cui Z; Han G
    Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.
    Carver BS; Chapinski C; Wongvipat J; Hieronymus H; Chen Y; Chandarlapaty S; Arora VK; Le C; Koutcher J; Scher H; Scardino PT; Rosen N; Sawyers CL
    Cancer Cell; 2011 May; 19(5):575-86. PubMed ID: 21575859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.
    He W; Zhang MG; Wang XJ; Zhong S; Shao Y; Zhu Y; Shen ZJ
    Int J Clin Exp Pathol; 2013; 6(12):2864-71. PubMed ID: 24294372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin-mediated upregulation of Sirt3 attenuates sodium fluoride-induced hepatotoxicity by activating the MT1-PI3K/AKT-PGC-1α signaling pathway.
    Song C; Zhao J; Fu B; Li D; Mao T; Peng W; Wu H; Zhang Y
    Free Radic Biol Med; 2017 Nov; 112():616-630. PubMed ID: 28912098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
    Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
    Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
    Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
    Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
    Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
    Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
    Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
    Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odontogenic ameloblast-associated protein (ODAM) inhibits human colorectal cancer growth by promoting PTEN elevation and inactivating PI3K/AKT signaling.
    Yu M; Mu Y; Qi Y; Qin S; Qiu Y; Cui R; Zhong M
    Biomed Pharmacother; 2016 Dec; 84():601-607. PubMed ID: 27694004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of E6-associated protein on the proliferation and invasion of prostate cancer cells in bone metastasis.
    Zhang L; Hu X; Chen J; Fu G
    Int J Clin Exp Pathol; 2015; 8(6):6571-5. PubMed ID: 26261538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT3 functions as a tumor suppressor in hepatocellular carcinoma.
    Zeng X; Wang N; Zhai H; Wang R; Wu J; Pu W
    Tumour Biol; 2017 Mar; 39(3):1010428317691178. PubMed ID: 28347248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grb2-associated binder 2 silencing impairs growth and migration of H1975 cells via modulation of PI3K-Akt signaling.
    Wang WJ; Mou K; Wu XF; Zhang JZ; Ren G; Qi JD; Xu YF; Yao X
    Int J Clin Exp Pathol; 2015; 8(9):10575-84. PubMed ID: 26617767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.
    Lee TJ; Sartor O; Luftig RB; Koochekpour S
    Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
    Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
    Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.